These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24114955)

  • 41. Assessing and Treating Patients With Neuropathic Pain.
    Scholten PM; Harden RN
    PM R; 2015 Nov; 7(11 Suppl):S257-S269. PubMed ID: 26568505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropathic pain therapy: from bench to bedside.
    Backonja MM
    Semin Neurol; 2012 Jul; 32(3):264-8. PubMed ID: 23117951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical treatment of neuropathic pain using compounded medications.
    Zur E
    Clin J Pain; 2014 Jan; 30(1):73-91. PubMed ID: 23446080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recommendations for neuropathic pain treatment.
    Demarin V; Basić-Kes V; Zavoreo I; Bosnar-Puretić M; Rotim K; Lupret V; Perić M; Ivanec Z; Fumić L; Lusić I; Aleksić-Shihabis A; Kovac B; Ivanković M; Skobić H; Maslov B; Bornstein N; Niederkorn K; Sinanović O; Rundek T; ;
    Acta Clin Croat; 2008 Sep; 47(3):181-91. PubMed ID: 19175069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients.
    Mercadante S; Gebbia V; David F; Aielli F; Verna L; Casuccio A; Porzio G; Mangione S; Ferrera P
    J Pain; 2009 Jun; 10(6):594-600. PubMed ID: 19231297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment.
    Vadalouca A; Siafaka I; Argyra E; Vrachnou E; Moka E
    Ann N Y Acad Sci; 2006 Nov; 1088():164-86. PubMed ID: 17192564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
    Maihofner C; Heskamp ML
    Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complex regional pain syndrome type I following trauma: a case-report.
    Zur E
    Int J Pharm Compd; 2014; 18(1):14-9. PubMed ID: 24881335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropathic pain: mechanisms and treatments.
    Ro LS; Chang KH
    Chang Gung Med J; 2005 Sep; 28(9):597-605. PubMed ID: 16323550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The clinical challenge of chronic neuropathic pain.
    Vissers KC
    Disabil Rehabil; 2006 Mar; 28(6):343-9. PubMed ID: 16492630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Peripheral neuropathic pain relieved by somatosensory rehabilitation].
    Mathis F; Desfoux N; Sprumont P; Hecker E; Rossier P; Spicher C
    Rev Med Suisse; 2007 Nov; 3(135):2745-8. PubMed ID: 18214230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuropathic pain.
    Basić-Kes V; Zavoreo I; Bosnar-Puretić M; Ivanković M; Bitunjac M; Govori V; Demarin V
    Acta Clin Croat; 2009 Sep; 48(3):359-65. PubMed ID: 20055264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Neuropathic pain].
    Bach FW; Finnerup NS; Jensen TS
    Ugeskr Laeger; 2006 May; 168(20):1964-6. PubMed ID: 16768895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasticity of complex regional pain syndrome (CRPS) in children.
    Stanton-Hicks M
    Pain Med; 2010 Aug; 11(8):1216-23. PubMed ID: 20704670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropathic Pain models caused by damage to central or peripheral nervous system.
    Kumar A; Kaur H; Singh A
    Pharmacol Rep; 2018 Apr; 70(2):206-216. PubMed ID: 29475003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The neuropathic components of chronic low back pain: a prospective multicenter study using the DN4 Questionnaire.
    Attal N; Perrot S; Fermanian J; Bouhassira D
    J Pain; 2011 Oct; 12(10):1080-7. PubMed ID: 21783428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropathic pain and pharmacological treatment.
    Jongen JL; Hans G; Benzon HT; Huygen F; Hartrick CT
    Pain Pract; 2014 Mar; 14(3):283-95. PubMed ID: 23750502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of cancer-related neuropathy and neuropathic pain.
    Cleeland CS; Farrar JT; Hausheer FH
    Oncologist; 2010; 15 Suppl 2():13-8. PubMed ID: 20489192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of neuropathic pain in primary care.
    Haanpää ML; Backonja MM; Bennett MI; Bouhassira D; Cruccu G; Hansson PT; Jensen TS; Kauppila T; Rice AS; Smith BH; Treede RD; Baron R
    Am J Med; 2009 Oct; 122(10 Suppl):S13-21. PubMed ID: 19801048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.